ATHN

You can help improve care.

When you join the study, your information will be de-identified, which means your name, or other identifying information, is not used, but your data will be assigned a unique, computer-generated code used to label your health information. This code system ensures confidentiality by allowing researchers to use your health data without knowing who you are.

Treatment options for GT are limited because we do not yet have a clear understanding of the types of bleeding symptoms that these patients experience and their response to the currently available treatments. You can make a difference by telling us what your symptoms are and how you respond to your treatment.

Thank you! Together we are making a difference.

To participate in the study, you will need to sign an informed consent form, have a confirmed GT diagnosis from a blood test, and be willing to keep a log of your bleeds and treatments for a short period of time.

There is power in numbers! People who join this study are helping researchers better understand Glanzmann Thrombasthenia and address important questions about the safety and effectiveness of treatments, all of which leads to better care and treatments.

Ready to Take the First Step? Locate a Study Site Near You!

By completing this form, you give ATHN permission to connect you with a treatment center in your area. You may then decide if you want to visit the center to learn more about the study.